Latest period
$116.58B
YoY change
+42.9%
5Y CAGR
+19.3%
Peak year (2025)
$112.48B
Latest annual
$112.48B
Total Assets history chart for Eli Lilly (LLY) from 1985 to 2025
Latest: $112.48B
Total Assets growth chart for Eli Lilly (LLY) from 1985 to 2025
Latest: +42.9%
Total Assets history table for Eli Lilly (LLY) from 1985 to 2025
| 2025 | $112.48B | +42.9% | +$33.76B | ||
| 2024 | $78.71B | +23.0% | +$14.71B | ||
| 2023 | $64.01B | +29.3% | +$14.52B | ||
| 2022 | $49.49B | +1.4% | +$683.80M | ||
| 2021 | $48.81B | +4.7% | +$2.17B | ||
| 2020 | $46.63B | +18.7% | +$7.35B | ||
| 2019 | $39.29B | -10.5% | −$4.62B | ||
| 2018 | $43.91B | -2.4% | −$1.07B | ||
| 2017 | $44.98B | +15.9% | +$6.18B | ||
| 2016 | $38.81B | +9.1% | +$3.24B | ||
| 2015 | $35.57B | -2.0% | −$738.70M | ||
| 2014 | $36.31B | +3.0% | +$1.06B | ||
| 2013 | $35.25B | +2.5% | +$849.80M | ||
| 2012 | $34.40B | +2.2% | +$739.10M | ||
| 2011 | $33.66B | +8.6% | +$2.66B | ||
| 2010 | $31.00B | +12.9% | +$3.54B | ||
| 2009 | $27.46B | -6.0% | −$1.75B | ||
| 2008 | $29.21B | +9.1% | +$2.42B | ||
| 2007 | $26.79B | +22.0% | +$4.83B | ||
| 2006 | $21.96B | -10.7% | −$2.63B | ||
| 2005 | $24.58B | -1.2% | −$286.20M | ||
| 2004 | $24.87B | +14.7% | +$3.19B | ||
| 2003 | $21.68B | +13.8% | +$2.64B | ||
| 2002 | $19.04B | +15.9% | +$2.61B | ||
| 2001 | $16.43B | +11.9% | +$1.74B | ||
| 2000 | $14.69B | +14.5% | +$1.87B | ||
| 1999 | $12.83B | +1.8% | +$229.70M | ||
| 1998 | $12.60B | +0.1% | +$18.10M | ||
| 1997 | $12.58B | -12.1% | −$1.73B | ||
| 1996 | $14.31B | -0.7% | −$105.30M | ||
| 1995 | $14.41B | -0.7% | −$94.90M | ||
| 1994 | $14.51B | +50.7% | +$4.88B | ||
| 1993 | $9.62B | +11.0% | +$950.80M | ||
| 1992 | $8.67B | +4.5% | +$374.20M | ||
| 1991 | $8.30B | +16.2% | +$1.16B | ||
| 1990 | $7.14B | +22.1% | +$1.29B | ||
| 1989 | $5.85B | +11.1% | +$585.30M | ||
| 1988 | $5.26B | +0.1% | +$7.80M | ||
| 1987 | $5.25B | +14.3% | +$659.10M | ||
| 1986 | $4.60B | +16.2% | +$642.10M | ||
| 1985 | $3.95B | — | — |
- 2025$112.48B+42.9%
- 2024$78.71B+23.0%
- 2023$64.01B+29.3%
- 2022$49.49B+1.4%
- 2021$48.81B+4.7%
- 2020$46.63B+18.7%
- 2019$39.29B-10.5%
- 2018$43.91B-2.4%
- 2017$44.98B+15.9%
- 2016$38.81B+9.1%
- 2015$35.57B-2.0%
- 2014$36.31B+3.0%
- 2013$35.25B+2.5%
- 2012$34.40B+2.2%
- 2011$33.66B+8.6%
- 2010$31.00B+12.9%
- 2009$27.46B-6.0%
- 2008$29.21B+9.1%
- 2007$26.79B+22.0%
- 2006$21.96B-10.7%
- 2005$24.58B-1.2%
- 2004$24.87B+14.7%
- 2003$21.68B+13.8%
- 2002$19.04B+15.9%
- 2001$16.43B+11.9%
- 2000$14.69B+14.5%
- 1999$12.83B+1.8%
- 1998$12.60B+0.1%
- 1997$12.58B-12.1%
- 1996$14.31B-0.7%
- 1995$14.41B-0.7%
- 1994$14.51B+50.7%
- 1993$9.62B+11.0%
- 1992$8.67B+4.5%
- 1991$8.30B+16.2%
- 1990$7.14B+22.1%
- 1989$5.85B+11.1%
- 1988$5.26B+0.1%
- 1987$5.25B+14.3%
- 1986$4.60B+16.2%
- 1985$3.95B—
Total Assets values are taken from Eli Lilly's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported total assets is $116.58B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Eli Lilly (LLY) reported total assets of $112.48B – surged 42.9% year-over-year.
Across 2020–2025 (5 years), Eli Lilly total assets produced a CAGR of +19.3% – sustaining 6 straight years of year-over-year growth.
The record annual total assets stands at $112.48B, reached in 2025; the historical low of $3.95B was recorded in 1985.
Eli Lilly Total Assets by Year
Eli Lilly Total Assets 2025: $112.48B
2025's total assets for Eli Lilly came in at $112.48B, surged 42.9% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Total Assets 2024: $78.71B
Eli Lilly posted total assets of $78.71B in 2024, grew 23.0% from 2023.
Eli Lilly Total Assets 2023: $64.01B
In 2023, Eli Lilly reported total assets of $64.01B, grew 29.3% from 2022.
Eli Lilly Total Assets 2022: $49.49B
Eli Lilly total assets in 2022 was $49.49B, edged up 1.4% from 2021.
Eli Lilly Total Assets 2021: $48.81B
Eli Lilly total assets in 2021 was $48.81B.
See more financial history for Eli Lilly (LLY).
Sector peers by Total Assets
Healthcare peers of Eli Lilly (LLY), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $110.34B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $110.34B
- $90.59B
- $85.37B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation